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Human milk oligosaccharides (HMos) are a mixture of structurally diverse carbohydrates that 
contribute to shape a healthy gut microbiota composition. the great diversity of the HMos structures 
does not allow the attribution of specific prebiotic characteristics to single milk oligosaccharides. 
We analyze here the utilization of four disaccharides, lacto‑N‑biose (LnB), galacto‑N‑biose (GnB), 
fucosyl-α1,3-GlcNAc (3FN) and fucosyl-α1,6-GlcNAc (6FN), that form part of HMOs and glycoprotein 
structures, by the infant fecal microbiota. LNB significantly increased the total levels of bifidobacteria 
and the species Bifidobacterium breve and Bifidobacterium bifidum. the Lactobacillus genus levels 
were increased by 3FN fermentation and B. breve by GNB and 3FN. There was a significant reduction 
of Blautia coccoides group with LNB and 3FN. In addition, 6FN significantly reduced the levels 
of Enterobacteriaceae family members. Significantly higher concentrations of lactate, formate 
and acetate were produced in cultures containing either LnB or GnB in comparison with control 
cultures. Additionally, after fermentation of the oligosaccharides by the fecal microbiota, several 
Bifidobacterium strains were isolated and identified. The results presented here indicated that each, 
LNB, GNB and 3FN disaccharide, might have a specific beneficial effect in the infant gut microbiota 
and they are potential prebiotics for application in infant foods.
Studies using in vitro analysis have shown that human milk unconjugated oligosaccharides (HMOs) and the 
glycan moiety of glycoproteins are effective in selectively promoting the growth of beneficial  bacteria1–3. Bifi-
dobacterium longum, Bifidobacterium bifidum, Bifidobacterium breve and Bifidobacterium catenulatum group 
are frequently isolated from breast-fed infant  feces4,5. Some species of Lactobacillus, including Lactobacillus 
reuteri, Lactobacillus casei and Lactobacillus rhamnosus are also constituents of the infant gastrointestinal  tract6,7. 
Among the bifidobacteria isolated from infant feces, there are important differences in the fermentation pat-
terns of HMOs, which have more than two hundred distinct  structures8–10, and this opens the possibility to 
accurately modulate the gut microbiota with specific  HMOs11. To date only a few analyses have determined the 
physiological impact of individual HMOs on the infant gut microbiota. Thus, an in vitro fermentation system 
with stool samples from formula-fed babies demonstrated that lacto-N-biose (LNB), the main building block 
of type-1 HMOs, increased the total bifidobacterial  population12. Especially B. bifidum numbers were highly 
induced in comparison to lactulose, raffinose, GOS or  mannanoligosaccharides12. Lacto-N-neotetraose and 
2′-fucosyllactose (2′FL) were fermented at a higher rate than 6′-sialyllactose in in vitro mixed culture systems 
by microbiota from breast or formula fed infants, but none of them showed an important effect in the number 
of  bifidobacteria13. Total HMOs purified from human milk increased the number of Bifidobacterium spp. while 
the number of Escherichia spp. and Clostridium perfringens diminished during in vitro fermentation of infant 
 microbiota1. In these cultures, most of the 2′FL, 3-fucosyllactose (3FL) and lactodifucotetraose (LDFT) from 
the HMOs supplement were consumed, suggesting that some specific oligosaccharides may be responsible of 
the prebiotic effect attributed to HMOs. A few studies using in vitro colon  models14 and in vivo animal models 
also underline the ability of individual HMOs to modify the composition of the gastrointestinal  microbiota15,16.
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HMOs are present at high concentrations in human milk but not in infant  formulas17. We have previously 
synthesized fucosyl- α-1,3-N-acetylglucosamine (3FN) and fucosyl-α-1,6-N-acetylglucosamine (6FN) using the 
transglycosylation activity of α-L-fucosidases18. 3FN forms part of  HMOs2 and 6FN of N-glycosylated proteins, 
including  mucins19. We have also produced LNB and galacto-N-biose (GNB), the core type-1 sugar from mucins, 
using the transgalactosylation activity of the β-galactosidase  GnbG20. The synthesized fucosyl-N-GlcNAc disac-
charides are fermented in vitro by pure cultures of L. casei, L. rhamnosus, B. breve and B. pseudocatenulatum 
 species21. Regarding LNB, it was fermented in vitro for all the strains tested of B. bifidum, B. infantis, B. longum 
subsp. longum and B. breve, and for some strains of B. pseudocatenulatum, Bifidobacterium animalis subsp. ani-
malis and Bifidobacterium pseudolongum22. In addition, we have seen that LNB and GNB are also fermented by 
pure cultures of Lactobacillus  species20. In this work, we have investigated, in batch cultures using total microbiota 
isolated from stool samples of breastfed infants, the effects of LNB, GNB, 3FN and 6FN on infant microbiota 
composition and subsequent short chain fatty acids production. Our final aim is to compare the potential prebi-
otic effect of those four disaccharides.
Results
Total and specific bacterial levels modulation with human milk disaccharides. The disaccha-
rides LNB, GNB, 3FN and 6FN were synthesized by transglycosylation reactions as previously  described20,21, 
and they were tested independently in fermentation assays, using total microbiota isolated from stool samples 
of breastfed infants. The addition of any of those oligosaccharides decreased the culture pH (Table 1). However, 
while the cultures with LNB and GNB resulted in a significant pH reduction (more than 2.5 pH units), the 
cultures with 3FN and 6FN showed a change in pH (about 1.0 pH unit) similar to the control culture without 
added sugar. These results are in agreement with the amount of oligosaccharides metabolized by the cultured 
infant microbiota, being the percentages of LNB and GNB consumed higher than the ones of the fucosylated 
oligosaccharides consumed (Table  1). Microbiota modulation was first determined at group and genus level 
by analyzing the numbers of total bacteria, Bacteroides, Bifidobacterium, Blautia cocoides group, Enterobacte-
riaceae family and Lactobacillus spp. Total bacterial numbers were similar among all the cultures, including the 
control (Fig. 1). Since the disaccharides were not completely consumed, that result suggested that they can be 
utilized only by a few selected groups of bacteria present in the infant microbiota. The results presented here 
(p = 0.0964, Dunnett’s test) (Fig. 1a) and previous studies, using fecal bacteria from formula-fed infants, showed 
that the total bifidobacterial community incremented with  LNB12. Contrary to Bifidobacterium genus, a signifi-
cant (p = 0.0192, Dunnett’s test) decrease in the number of cells during fermentation of LNB was observed for 
Blautia coccoides group (Fig. 1a). Regarding the fucosyl-N-acetylglucosamine disaccharides, the Lactobacillus 
genus is significantly (p = 0.0540, Dunnett’s test) increased by 3FN (Fig. 1c). 6FN has no significant effect in the 
cell numbers of lactobacilli respect to the control (Fig. 1d). Significantly (p = 0.0822, Dunnett’s test) lower cell 
numbers were observed for Blautia coccoides group in cultures containing 3FN and for Enterobacteriaceae family 
(p = 0.0751, Dunnett’s test) in cultures with 6FN (Fig. 1c and d).
Bifidobacterium and Lactobacillus species modulation with human milk disaccharides. In 
addition to Bifidobacterium and Lactobacillus abundance at the genus level, Bifidobacterium species (Bifido-
bacterium breve, Bifidobacterium bifidum, Bifidobacterium catenulatum group, Bifidobacterium animalis subsp. 
lactis and Bifidobacterium longum group) and Lactobacillus species (Lactobacillus acidophilus, L. casei subgroup 
and Lactobacillus reuteri subgroup) were also analyzed (Fig. 2). B. lactis, L. reuteri subgroup and L. acidophilus 
were below detection limit levels. LNB (p < 0.0001, Dunnett’s test), GNB (p < 0.0001, Dunnett’s test) or 3FN 
(p = 0.0011, Dunnett’s test) supplementation significantly increased the number of cells of B. breve compared 
to control culture (Fig. 2). In addition, B. bifidum was also incremented (p = 0.0808, Dunnett’s test) with LNB 
(Fig. 2a). In agreement with this, LNB has been previously shown as a substrate supporting the growth of strains 
belonging to B. breve and B. bifidum22. Although LNB is also a substrate for B. longum  species22 and they were 
in a high proportion compared with the other analyzed strains (Fig. 2a), there was not a significant cell number 
increase in the presence of that carbohydrate. In this respect, previous results showed that bifidobacteria incre-
ment in cultures with prebiotics is higher when these bacteria are at lower  levels23. The 16S rRNA gene copy 
numbers of total bifidobacteria are higher than the sum of the numbers of the four species (B. breve, B. bifidum, 
B. catenulatum group and B. longum group) tested here (Figs. 1 and 2). Although these species are usually the 
dominant bifidobacteria detected in the infant feces, the literature showed that there is an extraordinary vari-
ation in the individual composition of Bifidobacterium species in the infant  gut4. Therefore, the discrepancies 
observed between the 16S rRNA gene copy numbers might be due to the presence of other Bifidobacterium 
species that outcompete those generally infant gut-associated bifidobacterial species. Regarding 3FN, previous 
Table 1.  Decrease of pH values of culture supernatants and % of consumed oligosaccharides (mean ± standard 
deviation) from infant fecal microbiota fermentation assays. Control, without sugar added; LNB, lacto-N-biose; 
GNB, galacto-N-biose; 3FN, fucosyl-α-1,3-N-acetylglucosamine; 6FN, fucosyl-α-1,6-N-acetylglucosamine. 
aStatistical significant differences compared to control are indicated: *p < 0.05.
Control LNB GNB 3FN 6FN
pH
decreasea 0.83 ± 0.32 2.97 ± 0.26* 2.89 ± 0.27* 0.98 ± 0.34 0.95 ± 0.33
% consumed disaccharides - 82.33 ± 15.94 78.33 ± 19.40 41.92 ± 9.49 23.51 ± 15.57
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studies demonstrated that B. breve strain ATCC15700 was able to metabolize  it21. The numbers of B. bifidum 
declined significantly (p = 0.0927, Dunnett’s test) in cultures with 3FN and they showed a tendency to decrease 
with 6FN (Fig. 2c,d). Two extracellular cell-anchored α-L-fucosidases, AfcA and AfcB, that hydrolyze α-1,2- and 
α-1,3/1,4-linked fucosyl residues, respectively, have been characterized in that  species24,25. However, neither 3FN 
nor 6FN were catabolized by B. bifidum21, which is in agreement with the fact that those enzymes do not hydro-
lyze  them26. Interestingly no differences were observed in the numbers of L. casei subgroup (Fig. 2) although as 
mentioned above these species contain the metabolic pathways to utilize LNB, GNB and 3FN as energy sources. 
Therefore, these results suggested a competition with other bacterial species with probably higher affinity for 
those substrates.
Figure 1.  Total and specific bacterial levels measured with qPCR in cultures with fecal infant microbiota 
supplemented with oligosaccharides (clear bars). (a) lacto-N-biose (LNB); (b) galacto-N-biose (GNB); (c) 
fucosyl-α-1,3-N-acetylglucosamine (3FN); (d) fucosyl-α-1,6-N-acetylglucosamine (6FN). Control cultures 
are without carbohydrate added (dark bars). In all graphs, the data of the control is represented for better 
comparison. Data presented are mean values based on at least three replicates. Error bars indicate standard 
deviations. Statistically significant differences compared to control are indicated: #p < 0.1; *p < 0.05.
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Lactate, formate and ScfA production changes with human milk disaccharides. Fermenta-
tion of non-digestible carbohydrates by the gut microbiota in the large intestine results in the accumulation of 
SCFA. About 90–95% of the SCFA present in the colon are acetate, propionate and  butyrate27. Although lactate 
and formate are not SCFA, they are also major organic acids produced from the fermentation of carbohydrates 
by lactic acid  bacteria28,29. Therefore, the concentration of lactate, formate and SCFA due to oligosaccharide 
fermentation by the infant fecal microbiota batch cultures were analyzed (Table 2). Lactate, formate and acetate 
increased significantly in the presence of LNB or GNB compared to the un-supplemented media control. Previ-
ous results with cultures containing LNB as carbon source and inoculated with fecal samples from formula-fed 
infants also showed an important acetate  increment12. None of the tested sugars showed a butyrogenic effect in 
the cultures. Indeed, butyrate concentration significantly decreased with LNB and GNB fermentation (Table 2). 
Figure 2.  Bifidobacterium species/groups and Lactobacillus casei group levels measured with qPCR in cultures 
with fecal infant microbiota supplemented with oligosaccharides (clear bars). (a) lacto-N-biose (LNB); (b) 
galacto-N-biose (GNB); (c) fucosyl-α-1,3-N-acetylglucosamine (3FN); (d) fucosyl-α-1,6-N-acetylglucosamine 
(6FN). Control cultures are without carbohydrate added (dark bars). In all graphs, the data of the control is 
represented for better comparison. Data presented are mean values based on at least three replicates. Error bars 
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Previous results demonstrated that oral administration of B. breve resulted in a decrease of fecal butyrate pro-
duction in low birth weight  infants30. As described above in the cultures supplemented with LNB or GNB sig-
nificantly increased the cell counts of that species (Fig. 2), which might have a role lowering butyric acid levels. 
Additionally, Bacteroides and Blautia coccoides groups contain butyric acid producing  genera31 that likely derive 
amino acids present in the culture media towards the synthesis of  butyrate32. The availability of LNB or GNB in 
the cultures resulted in a tendency to decrease those bacterial groups with respect to the control (Fig. 1) and this 
could result in less production of butyric acid.
Identification of isolated Bifidobacterium species. Samples from the disaccharide fermentation cul-
tures were plated on MRS with mupirocin and cysteine in order to isolate Bifidobacterium species. Isolates were 
subjected to RAPD-PCR analysis and at least one representative of each band pattern was kept for subsequently 
species identification. Partial 16S rRNA gene sequencing led to the identification of one isolate as B. longum 
(Y485) and ten isolates as B. breve (Y486, Y487, Y488, Y490, Y491, Y492, Y493, Y495, Y496 and Y545). This 
result is in line with the fact that the latter species was stimulated by three out of the four disaccharides tested 
(Fig. 2). However, there are a number of cells of B. longum present in a high proportion in the cultures and there-
fore, other explanations for that result cannot be  discarded33. Previous studies proved that RAPD-PCR analysis 
is an appropriate molecular tool to differentiate bifidobacteria at the strain  level34. The RAPD-PCR profiles were 
almost similar in all isolated B. breve strains, suggesting that they were closely related (Fig. 3). However, the clus-
ter analysis of RAPD-PCR profiles allowed differentiating the ten isolates to at least six different strains (Fig. 3). 
The B. longum strain Y485 and the B. breve strains Y486, Y490, Y491, Y492, Y496 and Y545 were selected to 
characterize their ability to utilize LNB, GNB, 3FN and 6FN. The B. breve type strain (ATCC 15700) was also 
included in this analysis. The ability of this strain to ferment 3FN was already demonstrated in our lab and it was 
used here as a positive  control21. The results demonstrate that all the Bifidobacterium strains tested were able to 
ferment LNB and GNB as evidenced by the decreased pH of the culture media (Fig. 4). 3FN was not utilized by 
Table 2.  Lactate, formate and short-chain fatty acids concentration (mM) (mean ± standard deviation) in 
infant fecal microbiota fermentation with oligosaccharides. Control, without sugar added; LNB, lacto-N-biose; 
GNB, galacto-N-biose; 3FN, fucosyl-α-1,3-N-acetylglucosamine; 6FN, fucosyl-α-1,6-N-acetylglucosamine. 
Statistical significant differences compared to control are indicated: #p < 0.1; *p < 0.05.
Control LNB GNB 3FN 6FN
Lactate 1.12 ± 0.14 4.93 ± 1.73* 4.48 ± 3.71* 1.06 ± 0.154 0.78 ± 0.36
Formate 2.43 ± 0.67 3.69 ± 0.38* 4.62 ± 0.44* 2.64 ± 0.91 2.77 ± 0.85
Acetate 3.67 ± 0.83 9.19 ± 5.44* 7.55 ± 1.78# 3.67 ± 1.07 3.61 ± 1.12
Propionate 1.45 ± 0.94 1.80 ± 0.86 3.07 ± 2.02 1.15 ± 0.62 0.87 ± 0.58
Butyrate 11.96 ± 3.80 6.84 ± 2.69# 6.75 ± 4.85# 10.62 ± 2.47 11.23 ± 1.61
Figure 3.  Evaluation of the genetic diversity among the Bifidobacterium breve strains isolated in this study using 
RAPD-PCR analysis. Agarose gel (2%) electrophoresis (a) and cluster analysis (b) of the DNA band patterns 
obtained from the B. breve strains Y486, Y487, Y488, Y490, Y491, Y492, Y493, Y495, Y496 and Y545. The type 
strain B. breve ATCC15700 was used as control. Cluster analysis was performed using the unweight pair group 
method with arithmetic mean (UPGMA) analysis. The numbers in the dendrogram provide a measure of 
genetic distances between isolates. Lane M, DNA molecular weight marker.
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B. longum strain Y485 but it was fermented by all the B. breve strains tested. None of the strains fermented 6FN 
(Fig. 4).
Discussion
Studies using in vitro analysis and animal models suggested that human milk oligosaccharides (HMOs) are 
crucial for modulating the infant gut microbiota and exerting important health benefits, including preven-
tion of pathogen attachment and  immunomodulation2,35–37. However, HMOs are not present or are present 
in low concentrations in infant  formulas17. Therefore, there is a need to evaluate the influence of individual 
carbohydrates in the microbiota profile of newborns for their selection as prebiotic substrates. In this work, the 
disaccharides LNB, GNB, 3FN and 6FN, that form part of HMOs and mucosa-associated glycans, were tested 
individually in fermentation assays, using total microbiota isolated from stool samples of breastfed infants. 
Total levels of bifidobacteria were significantly increased by LNB. The effect of this disaccharide was previously 
analyzed in vitro on fecal bacteria from formula-fed infants and the total bifidobacterial community was also 
 incremented12. These findings and our results confirmed LNB as an important growth-promoting factor for 
the genus Bifidobacterium. The transport and catabolism of LNB as well as GNB are mediated by the proteins 
encoded by the LNB/GNB gene cluster present in several Bifidobacterium  species38–41. This gene cluster includes 
a key enzyme, the LNB/GNB phosphorylase (LNBP), which catalyzes the cleavage of the 1,3-β-glycosidic bond 
of LNB or GNB into galactose-1-phosphate and GlcNAc or GalNAc,  respectively42. LNBP from Bifidobacterium 
species showed similar affinity for LNB and GNB, however, phosphorylases specific to GNB has also been char-
acterized in intestinal  bacteria43, which might explain the significant and nonsignificant differences found here 
between LNB and GNB, respectively, on Bifidobacterium cell counts (Fig. 1). Regarding lactobacilli, the operon 
gnb involved in the metabolism of LNB and GNB has been characterized in L. casei44. In this bacterium, those 
disaccharides are transported and phosphorylated by the  PTSGnb and once inside the cell are hydrolyzed by the 
specific phospho-β-1,3-galactosidase GnbG. In addition to L. casei, the species Lactobacillus rhamnosus, Lacto-
bacillus zeae, Lactobacillus gasseri and Lactobacillus johnsonii are also able to utilize LNB and GNB as a carbon 
 source20. However, while L. rhamnosus and L. zeae contain a phospho-β-galactosidase homologous to GnbG, L 
gasseri and L. johnsonii do not have GnbG homologs, suggesting that the catabolism of both sugars in the latest 
species must depend on other  glycosidases20.
Our results showed that the cell numbers of the Bacteroides and Blautia coccoides groups have a tendency to 
decrease during fermentation of LNB or GNB. BLAST searches using the amino acid sequence of LNBP from 
B. bifidum22 against the phylum Bacteroidetes did not show relevant homology with any protein. Analysis using 
GnbG from L. casei44 showed significant homology with proteins from several species belonging to Bacteroi-
detes, such as Sphingobacterium faecium45, Hymenobacter sp.46, Chryseobacterium sp.47 or Mucilaginibacter sp.48. 
However, the primers used to target Bacteroides  group49 do not amplify the 16S rRNA gene of those genera and 
in addition, they are isolated from environments different from the intestine. These results suggested the absence 
of enzymes homologs to LNBP and GnbG in gut species of the Bacteroides group, however, other enzymatic 
strategies to metabolize those disaccharides cannot be discarded. Alternatively, the decrease of Bacteroides group 
counts might also be explained by the pH reduction determined in cultures with LNB or GNB since some Bacte-
roides species showed a poor growth at low  pH50. Regarding B. coccoides group, some species contain homologs 
to LNBP and GnbG, although the possible role of these enzymes on LNB and GNB metabolism needs to be 
investigated.
Figure 4.  Decrease of pH values of culture supernatants from Bifidobacterium longum strain Y485 and 
Bifidobacterium breve strains Y486, Y490, Y491, Y492, Y496, Y545 and ATCC 15,700 cultured in MRS 
basal medium supplemented with 10 mM lacto-N-biose (LNB), galacto-N-biose (GNB), fucosyl- α-1,3-N-
acetylglucosamine (3FN) or fucosyl-α-1,6-N-acetylglucosamine (6FN). Data presented are mean values based 
on at least three replicates. Error bars indicate standard deviations.
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The fucosyl-disaccharide 3FN is hydrolyzed by the α-L-fucosidase AlfB from L. casei51 and the ability of this 
bacterium to ferment 3FN rely upon this  enzyme21,52. Homologs to AlfB are present in strains of the L. casei/L. 
paracasei/L. rhanmosus group and other lactobacilli species, including Lactobacillus sharpeae, Lactobacillus 
fabifermentans, Lactobacillus paralimentarius, Lactobacillus tucceti, Lactobacillus ghanensis, Lactobacillus apis, 
Lactobacillus vini, Lactobacillus gigeriorum, Lactobacillus panisapium and Lactobacillus helsingborgensis (https 
://www.ncbi.nih.gov/genom e). In accordance with this, the Lactobacillus genus is significantly increased by 3FN 
(Fig. 1c), although whether the lactobacilli present in the fermentation cultures analyzed here contain homologs 
to AlfB would require further analysis. As well, other catabolic systems different to those already characterized 
for 3FN utilization might exist. Regarding 6FN, lactobacilli cell counts were not affected. Curiously, 6FN is 
cleaved by the α-L-fucosidase AlfC from L. casei strain  BL2351, but unlike 3FN, it is not a metabolic substrate 
for this bacterium. The alfC gene forms part of the alf2 operon that is induced by the glycoamino acid 6FN-Asn, 
a constituent of the mammalian N-glycoproteins, but not by its glycan moiety  6FN53. L. casei strain BL87 and L. 
rhamnosus BL327 contain homologs to AlfC and they are able to metabolize 6FN although with low  efficiency21. 
BLAST searches using the amino acid sequences of AlfB and AlfC from L. casei51 against Blautia coccoides group 
and Enterobacteriaceae, respectively, did not show relevant homology with any protein, suggesting the absence of 
enzymes homologs to those α-L-fucosidases. However, the presence on those bacterial groups of other enzymes 
able to catabolize 3FN and 6FN cannot be ruled out. The reduced numbers of Enterobacteriaceae in the presence 
of 6FN, might be relevant for specific infant gastrointestinal disorders such as the development of necrotizing 
enterocolitis, which has been associated with an increased relative abundance of Enterobacteriaceae  strains54.
The major products of non-digestible carbohydrate metabolism by the gut microbiota are SCFA and organic 
acids such as formate and lactate. Both, organic acids and SCFA, resulted in a decrease of the luminal pH, which 
in turn resulted in inhibition of pathogens growth and increment of nutrients  absorption55. SCFA are a source 
of energy for  colonocytes56 and also for some members of the  microbiota31. In addition, SCFA have important 
roles in colorectal cancer, immune system and inflammatory  responses57. The fermentation of LNB and GNB 
by the infant microbiota resulted in an increment of the production of lactate, formate and acetate (Table 2). 
According to this, Bifidobacterium species produced both acetate and lactate through the “bifid-shunt” route 
during carbohydrate  fermentation58. Stool pH of breastfed infants is lower than that of bottle-fed  infants59 and 
it is due to the high lactate and acetate levels present in the feces of breastfed  infants11,60. Interestingly, research 
using an animal model has demonstrated that increased production of acetate by bifidobacteria protects the 
host against enteropathogenic  infection61. Lactate has also been shown to be important in maintaining intestinal 
barrier function through stimulation of enterocyte proliferation in a murine  model62. Although the cell numbers 
of lactobacilli and B. breve increase after fermentation of 3FN by the infant microbiota, there is not an incre-
ment in the production of lactate. Previous studies have shown that in anaerobiosis the L-fucose metabolism by 
some bacteria produces more efficiently 1,2-propanediol than  lactate63,64. However, this metabolite has not been 
detected in the supernatants from the 3FN-supplemented cultures (data not shown), suggesting that either it 
was not produced or if produced, it was further metabolized by other members of the microbiota present in the 
fermentation cultures. Some bacteria utilize 1,2-propanediol, via propionaldehyde, to produce propionate and/
or  propanol31. Since the concentration of propionate did not increase with 3FN, the possible 1,2-propanediol 
produced would be derived to propanol. Whether the lactobacilli and bifidobacteria present in the fermenta-
tion cultures analyzed here produce 1,2-propanediol, that is further derived to propanol by other bacteria also 
present in the cultures, is unknown. Additional studies will be needed to find out why the lactate levels do not 
change in the cultures with 3FN.
This study demonstrates that the human milk and mucosa-associated disaccharides LNB, GNB and 3FN and 
6FN are fermented in vitro by the microbiota isolated from stool samples of breastfed infants. The results pre-
sented here allow a comparison among four individual disaccharides and they indicated that each disaccharide 
distinctly modulates the microbiota composition and activity. The growth of specific Bifidobacterium species is 
significantly promoted by LNB, GNB and 3FN, and the growth of lactobacilli by 3FN. Furthermore, LNB and 
GNB enhance the production of lactate, formate and acetate. Regarding 6FN, Enterobacteriaceae family counts 
are significantly reduced, although further work is needed to determine the relevance of this finding. Overall, our 
results highlight the prebiotic potential of each LNB, GNB and 3FN for application in functional infant foods.
Methods
Enzymatic synthesis and purification of human milk disaccharides. The disaccharides LNB, GNB, 
3FN and 6FN were produced in our laboratory as previously  described18,20,21. Briefly, transgalactosylation reac-
tions containing 100 mM Tris–HCl buffer, pH 7.5, o-nitrophenyl β-D-galactopyranoside 40 mM, 0.17 U/ml of 
GnbG and N-acetylglucosamine (GlcNAc) 200 mM or N-acetylgalactosamine (GalNAc) 200 mM were carried 
out at 42 °C for 3 h to synthesize LNB and GNB, respectively. Transfucosylation reactions containing 100 mM 
Tris–HCl buffer, pH 7.0, p-nitrophenyl α-L-fucopyranoside 50 mM, N-acetylglucosamine (GlcNAc) 150 mM 
and 180 U/ml of AlfB or 800 U/ml AlfC, were carried out at 42 °C for 15 min (AlfB) and 10 min (AlfC) to syn-
thesize 3FN and 6FN, respectively.
The transglycosylation reaction products were purified by high-performance liquid chromatography (HPLC) 
with a Jasco PU2080Plus system coupled to a refractive index detector (Jasco RI-2031 Plus) using a preparative 
Rezex RCM-Monosaccharide column (Phenomenex, Torrance, CA, USA), as described  previously21. Based on 
HPLC analysis, the purity of the synthesized oligosaccharides was found to be more than 99%.
Batch culture fermentation assays. Stool samples from five healthy infants exclusively breast-fed and 
two months old were selected from a previous  study65. A pooled fecal sample was used to isolate the micro-
biota as previously  described66. Two grams of feces were homogenized in 18 ml of physiological serum (NaCl 
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0.9%), placed on top of 3.5 ml Nycodenz 80% solution (Alere Technologies AS) and centrifuged for 1 h at 3,327 
xg (Hermle Z383K). The layer containing the microbiota was collected and stored in 20% glycerol at – 80 °C. 
This microbiota was used to inoculate two ml of basal medium containing bactopeptone (Difco), 2 g/L; yeast 
extract (Pronadisa), 2 g/L; NaCl 0.1 g/L;  K2HPO4 0.04 g/L;  KH2PO4 0.04 g/L;  MgSO4·7H2O 0.01 g/L;  CaCl2·H2O 
0.01 g/L;  NaHCO3 2 g/L; L-cysteine 0.5 g/L; bile salts 0.5 g/L; Tween 80 2 ml/L; haemin solution 0.05 g/L (Sigma); 
vitamin  K1 (Sigma), 10 μl/L; and resazurin 0.025% solution, 4 ml/L. The pH of the medium was adjusted to 7.4. 
Four cultures were initiated with the purified disaccharides, LNB, GNB, 3FN or 6FN at 10 mM. A control culture 
without carbohydrate added was also included. Cultures were grown at 37 °C under anaerobic conditions using 
an anaerobic atmosphere generation system (Anaerogen, Oxoid), and at 48 h they were centrifuged, and pellets 
and supernatants were collected. Three independent cultures were carried out for each oligosaccharide.
Quantification of bacterial groups, genera and species by specific real-time PCR. Bacte-
rial DNA was extracted from each pellet of the cultures using the MasterPure DNA extraction Kit (Epicentre) 
according to the manufacturer’s instructions with some modifications. These include a previous treatment with 
lysozyme and mutanolysin for 60 min at 37 °C followed by cell disruption with 0.1 mm diameter glass beads. 
DNA concentration was measured using a Qubit 2.0 Fluorometer (Life Technology).
Quantitative real-time PCR (qPCR) assays were performed as previously  described67 and using a series of 
bacterial group, genus and species-specific 16S rRNA gene primer  pairs49,67–74 listed in supplementary Table S1. 
The qPCR amplification and detection were performed in a LightCycler 480 Real-Time PCR System (Roche 
Technologies). Each reaction mixture (10 μl) contained SYBR Green PCR Master Mix (Roche), 0.25 μl of each 
primer (10 μM) and 1 μl of template DNA. All samples were analyzed in duplicate. Standard curves obtained by 
using serial tenfold dilutions of specific DNA fragments were used to calculate bacterial concentration in each 
sample. A detection limit of 100 copies per reaction was established.
Analysis of disaccharide consumption. To determine the carbohydrates present in the supernatants 
from the infant fecal microbiota fermentation assays, filtered culture supernatants were analyzed by high-pH 
anion-exchange chromatography with pulsed amperometric detection in a ICS3000 chromatographic system 
(Dionex) using a CarboPac PA100 column. A gradient of 10 to 100 mM NaOH was used at 27 °C for 15 min 
at a flow rate of 1 ml/min. Disaccharides were confirmed by comparison of their retention times with those 
of standards. The obtained calibration curves for LNB, GNB, 3FN and 6FN were linear in the range tested, 
0.05–0.25 mM.
Lactate, short-chain fatty acids and 1,2-propanediol analysis. Filtered culture supernatants were 
analyzed by HPLC with a Jasco PU2080Plus system coupled to a UV (210 nm) or refractive index (Jasco RI-
2031Plus) detectors and using a Rezex ROA-Organic Acid or Rezex RCM-Monosaccharide columns (Phenom-
enex, Torrance, CA, USA). Lactic, formic, acetic, propionic, butyric acids (Rezex ROA-Organic Acid column) 
and 1,2-propanediol (Rezex RCM-Monosaccharide column) were determined as previously  described63,75. The 
column temperatures were kept at 40 °C and 80 °C, respectively, in phosphoric acid 0.1% or water.
isolation of Bifidobacterium species. A dilution series was made from the LNB, GNB, 3FN and 6FN 
fermentation cultures, and 0.1  ml aliquots were plated on MRS agar with mupirocin 50  mg/L and cysteine 
0.1%. These plates were incubated in anaerobic jars at 37 °C for 72 h in order to isolate Bifidobacterium species. 
More than ten colonies from each of the four disaccharide-supplemented cultures were selected until reaching 
a total number of fifty colonies. These were subsequently subjected to randomly amplified polymorphic DNA 
(RAPD) analysis. Each RAPD-PCR reaction (25 μl) contained bacterial cells from the colonies as source of DNA 
template, random primer  MCV76 described in Table S1 at a final concentration of 2 μM, 400 μM of each dNTP, 
 MgCl2 4 mM, dimethyl sulfoxide (DMSO) 4%, 2 U of Taq DNA polymerase and PCR buffer (NZYtech). Amplifi-
cations were performed at 96 °C for 7 min, followed by 35 cycles of 30 s at 95 °C, 45 s at 30 °C and 1 min at 72 °C 
and extension for 7 min at 72 °C. Samples were analyzed by agarose gel electrophoresis and one representative 
isolate of each band pattern was kept for further analysis. Partial 16S rRNA gene of these bacterial isolates was 
amplified by PCR using cells from the colonies as the template and the primers  27F77 and  924R78 (Table S1). The 
PCR products were sequenced by the Central Service of Research Support of the University of Valencia (Spain). 
The sequences were used in BLAST searches to identify each isolated.
Genetic distance between the B. breve isolates was calculated using the Dice coefficient of similarity and the 
strains were clustered in a dendrogram using the unweight pair group method with arithmetic mean (UPGMA) 
analysis with PyElph 1.4 software  tool79.
The growth of individual B. longum and B. breve strains in the presence of each disaccharide at 10 mM was 
tested in MRS basal medium using the culture conditions previously described for the Bifidobacterium  strains21.
Statistical analysis. One-way ANOVA with Dunnett’s multiple comparisons test was performed using 
GraphPad Prism, version 6.07 (GraphPad Software Inc., San Diego, CA, USA) and it was used to detect statisti-
cally significant differences between the control and the disaccharide-supplemented groups (LNB, GNB, 3FN 
and 6FN) on the following: numbers of total and specific bacterial groups, genera and species; pH decrease 
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nucleotide sequence accession numbers. The partial nucleotide sequence of the 16S rRNA gene ampli-
cons have been deposited at the GenBank database under the accession numbers MN650609 to MN650619.
ethical statement. All applicable international, national, and/or institutional guidelines for the use of 
human samples were followed. Samples were selected from the project “The power of maternal microbes on 
infant health (MAMI)”. The study protocol with the registration number 2015/0024 was approved by the Ethics 
Committee of Spanish National Research Council (CSIC). Written informed consent is obtained from a parent 
and/or legal guardian.
Data availability statement. All data generated or analyzed during this study are included in this pub-
lished article.
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